Approvals/TGA/ZEMAIRA human alpha1-proteinase inhibitor 5 g powder for injection vial with diluent vial

Approved

STANDARD

ZEMAIRA human alpha1-proteinase inhibitor 5 g powder for injection vial with diluent vial

CSL Behring (Australia) Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: d6d74194e8d8fda7
Product Name: ZEMAIRA human alpha1-proteinase inhibitor 5 g powder for injection vial with diluent vial
Artg Id: 315073
Artg Name: ZEMAIRA human alpha1-proteinase inhibitor 5 g powder for injection vial with diluent vial
Sponsor: CSL Behring (Australia) Pty Ltd
Company Detail Path: /organization/csl-behring-australia-pty-ltd
Artg Date: 2020-05-14
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

d6d74194e8d8fda7

Type

Standard